Pictet Asset Management
PLRX icon

Pictet Asset Management’s Pliant Therapeutics PLRX Stock Holding History

Pictet Asset Management’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,266,030
Closed -$16.7M – 2061
2024
Q4 		$16.7M Sell
1,266,030
-13,687
-1% -$187K 0.02% 553
2024
Q3 		$14.3M Buy
1,279,717
+83,938
+7% +$1.05M 0.02% 566
2024
Q2 		$12.9M Sell
1,195,779
-111,832
-9% -$1.44M 0.01% 583
2024
Q1 		$19.5M Sell
1,307,611
-11,193
-0.8% -$185K 0.02% 498
2023
Q4 		$23.9M Buy
1,318,804
+417,514
+46% +$6.35M 0.03% 440
2023
Q3 		$15.6M Buy
+901,290
New +$15.6M 0.02% 525

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Pictet Asset Management's PLRX Position: Q1 2025 in Review

Pictet Asset Management sold out of Pliant Therapeutics (PLRX) in Q1 2025, closing a stake of 1,266,030 shares — an estimated $16.7M sold.

Pictet Asset Management first reported a position in PLRX in Q3 2023 and held it in 6 quarters. The position peaked at $23.9M in Q4 2023. 140 funds tracked by Wall St. Rank hold PLRX as of Q1 2025.

  • Pictet Asset Management reported no remaining Pliant Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Pictet Asset Management sold 1,266,030 Pliant Therapeutics shares in Q1 2025, an estimated $16.7M.
  • Pictet Asset Management first reported a position in Pliant Therapeutics in Q3 2023 and held it in 6 quarters.
  • Pictet Asset Management's Pliant Therapeutics position peaked at $23.9M in Q4 2023.
  • 140 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2025.

Based on Pictet Asset Management's 13F filing for Q1 2025, filed 5 May 2025.